Taiwan Biomaterial Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 16.543 million compared to TWD 1.004 million a year ago. Operating loss was TWD 73.053 million compared to TWD 67.912 million a year ago. Net loss was TWD 71.299 million compared to TWD 60.541 million a year ago. Basic loss per share was TWD 2.25 compared to TWD 2.02 a year ago.